Will European Stem Cell Ruling Stifle Research?
My commentary on patenting stem cell techniques was published by LexisNexis and is available to view here.
Partner
Mark Tudor
01923 215066
mark.tudor@mablaw.com
Mark is an expert in dispute resolution, including commercial litigation, IP/IT litigation, HFEA regulatory affairs.
His clients include Epicor Software (UK) Limited, Coface UK and Europcar UK Limited.
Latest news and views from Mark Tudor
RSSCivil Procedure Rules (“CPR”) Amendments
The 52nd update to the CPR is due to come into force on 30 April 2010. An amendment to Part 55 Possession Claims will require the claimant to notify a registered proprietor of a registered charge where...
Tax Health Plan
HM Revenue & Customs (HMRC) has introduced its inappropriately named “Tax Health Plan” which is an opportunity for medical professionals such as doctors, medical specialists, surgeons and consultants...
Deprivation of Liberty – The Bournewood Amendments: What do they mean for your care home?
From April 2009, by a wholesale amendment of the Mental Capacity Act 2005 (the “Bournewood Amendments”) Care Homes are forbidden to deprive residents of their liberty unless a strict and rigorous procedure...
Free advice for care homes – Deprivation of Liberty, the Bournewood Amendments: How to obtain authorisation.
The Authorisations
It may be a comfort to know that the ultimate responsibility for deciding whether DoL is necessary, rests with the appropriate local authority (known as the “Supervisory Body”)...
